Paul Blezinger

534 total citations
10 papers, 449 citations indexed

About

Paul Blezinger is a scholar working on Molecular Biology, Immunology and Nutrition and Dietetics. According to data from OpenAlex, Paul Blezinger has authored 10 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Nutrition and Dietetics. Recurrent topics in Paul Blezinger's work include Immunotherapy and Immune Responses (3 papers), Infant Nutrition and Health (3 papers) and Respiratory viral infections research (2 papers). Paul Blezinger is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Infant Nutrition and Health (3 papers) and Respiratory viral infections research (2 papers). Paul Blezinger collaborates with scholars based in United States, Italy and United Kingdom. Paul Blezinger's co-authors include Alain Rolland, Arun Singhal, Jijun Wang, Min Wang, Margaret Gondo, Seán M. Sullivan, Robert Ralston, Abraham Quezada, Martha French and Atul Varadhachary and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Paul Blezinger

9 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Blezinger United States 7 310 120 99 77 64 10 449
Richard Kay United Kingdom 9 270 0.9× 73 0.6× 91 0.9× 30 0.4× 170 2.7× 14 557
Wolfgang Ebel United States 9 285 0.9× 54 0.5× 144 1.5× 79 1.0× 190 3.0× 11 675
D Baban United Kingdom 8 340 1.1× 99 0.8× 47 0.5× 24 0.3× 107 1.7× 17 508
Shufeng Li China 17 375 1.2× 197 1.6× 53 0.5× 32 0.4× 65 1.0× 39 643
Garrett J. Brinkley United States 10 313 1.0× 143 1.2× 89 0.9× 23 0.3× 226 3.5× 14 611
Radhashree Maitra United States 16 347 1.1× 72 0.6× 167 1.7× 79 1.0× 295 4.6× 57 773
Kazuhide Okazawa Japan 7 151 0.5× 61 0.5× 46 0.5× 22 0.3× 71 1.1× 8 474
K. Sheth Saudi Arabia 11 129 0.4× 137 1.1× 90 0.9× 59 0.8× 147 2.3× 15 504
Ghassan Alusi United Kingdom 16 225 0.7× 64 0.5× 283 2.9× 108 1.4× 240 3.8× 36 723
Nicolas Belloy France 11 203 0.7× 75 0.6× 60 0.6× 22 0.3× 35 0.5× 26 504

Countries citing papers authored by Paul Blezinger

Since Specialization
Citations

This map shows the geographic impact of Paul Blezinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Blezinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Blezinger more than expected).

Fields of papers citing papers by Paul Blezinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Blezinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Blezinger. The network helps show where Paul Blezinger may publish in the future.

Co-authorship network of co-authors of Paul Blezinger

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Blezinger. A scholar is included among the top collaborators of Paul Blezinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Blezinger. Paul Blezinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Salameh, Ahmad, Paul Blezinger, Christine Gagliardi, et al.. (2023). 853 Evofosfomide potentiates the efficacy of a novel anti-PD-L1/PD-L2 monoclonal antibody against immune excluded tumors. SHILAP Revista de lepidopterología. A952–A952.
2.
Gagliardi, Christine, Federica Pericle, Ahmad Salameh, Paul Blezinger, & Michael A. Curran. (2022). 1333 Development of IMGS-001, a novel anti-PD-L1/PD-L2 dual specific, multi-functional antibody, to treat immune excluded tumors. Regular and Young Investigator Award Abstracts. A1384–A1384. 1 indexed citations
3.
Blezinger, Paul, et al.. (2008). Talactoferrin Stimulates Wound Healing With Modulation of Inflammation. Journal of Surgical Research. 149(2). 278–286. 47 indexed citations
4.
Spadaro, Michela, Claudia Curcio, Atul Varadhachary, et al.. (2007). Requirement for IFN-γ, CD8+ T Lymphocytes, and NKT Cells in Talactoferrin-Induced Inhibition of neu+ Tumors. Cancer Research. 67(13). 6425–6432. 30 indexed citations
5.
Varadhachary, Atul, Michela Spadaro, Paul Blezinger, et al.. (2006). Talactoferrin alfa is an anti-cancer agent with activity in renal cell cancer (RCC) patients and a novel immunomodulatory mechanism of action. Journal of Clinical Oncology. 24(18_suppl). 14648–14648. 3 indexed citations
6.
Blezinger, Paul, Guoyong Yin, Liang Xie, et al.. (1999). Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models. Angiogenesis. 3(3). 205–210. 11 indexed citations
7.
Blezinger, Paul, Jijun Wang, Margaret Gondo, et al.. (1999). Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nature Biotechnology. 17(4). 343–348. 256 indexed citations
8.
Blezinger, Paul, Bruce Freimark, Majed Matar, et al.. (1999). Intratracheal Administration of Interleukin 12 Plasmid-Cationic Lipid Complexes Inhibits Murine Lung Metastases. Human Gene Therapy. 10(5). 723–731. 40 indexed citations
9.
Blezinger, Paul, et al.. (1998). Target Specific Optimization of Cationic Lipid-Based Systems for Pulmonary Gene Therapy. Pharmaceutical Research. 15(9). 1340–1347. 37 indexed citations
10.
Pillai, Ravi, Karel Petrak, Paul Blezinger, et al.. (1998). Ultrasonic Nebulization of Cationic Lipid-Based Gene Delivery Systems for Airway Administration. Pharmaceutical Research. 15(11). 1743–1747. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Kay Breakdown of academic impact, for papers by Wolfgang Ebel Breakdown of academic impact, for papers by D Baban Breakdown of academic impact, for papers by Shufeng Li Breakdown of academic impact, for papers by Garrett J. Brinkley Breakdown of academic impact, for papers by Radhashree Maitra Breakdown of academic impact, for papers by Kazuhide Okazawa Breakdown of academic impact, for papers by K. Sheth Breakdown of academic impact, for papers by Ghassan Alusi Breakdown of academic impact, for papers by Nicolas Belloy
Rankless by CCL
2026